JANEIL SENDI: Open Payments
NPI 1699548289 · ARLINGTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$701 in 25 payments from 6 companies in 2025. Trend: 2023 $20 · 2024 $556 · 2025 $701
Food & beverage: $701
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $213 |
| ABBVIE INC. | 5 | $196 |
| Vanda Pharmaceuticals Inc. | 7 | $186 |
| Axsome Therapeutics, Inc. | 2 | $55 |
| Lilly USA, LLC | 1 | $28 |
| PFIZER INC. | 1 | $23 |
Products named: CAPLYTA, VRAYLAR, HETLIOZ, FANAPT, Auvelity, ZEPBOUND, NURTEC ODT.
Industry payments across VA — which companies pay providers there.
